<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00174174</url>
  </required_header>
  <id_info>
    <org_study_id>920203l</org_study_id>
    <nct_id>NCT00174174</nct_id>
  </id_info>
  <brief_title>Provigil (Modafinil) Study by Taiwan Biotech Co.</brief_title>
  <official_title>A Placebo Control, Double Blind, Cross Over Study of Modafinil in Patients With Narcolepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      The primary objective is to evaluate the therapeutic effect of excessive daytime sleepiness
      associated with narcolepsy. Both of the subjective and objective sleepiness of the patients
      were assessed in the experiment by repeat measures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change from baseline in the sleep latency.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's assessment of general level of daytime sleepiness on ESS.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's cognitive function assessed by psychomotor function test (Trail making test, and Digit Symbol Substitution Test).</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's sleep quality evaluated by PSQI.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety would be evaluated by tabulating and summarizing all adverse events reported.</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Narcolepsy</condition>
  <condition>Cataplexy</condition>
  <condition>Sleep Disorders</condition>
  <condition>Hypersomnolence</condition>
  <condition>Excessive Sleepiness</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Modafinil</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Polysomnographic findings of shortened sleep latency less than 5 minutes average of
             Multiple Sleep Latency Test, and two or more SOREM should be fulfilled.

          -  Age of 12 y/o to 55 y/o.

          -  The liver and kidney functions are within normal limits.

          -  Meeting the strict criteria of narcolepsy described above.

          -  Wash out any medications which might enhance wakefulness or affect nocturnal sleep two
             weeks prior to the experiments.

          -  Willingness to comply with the protocol and signed the written Informed Consent.

        Exclusion Criteria:

          -  Patients whose hypersomnia was caused by severely sleep deprived, phase delayed, or
             suspected long sleeper.

          -  Patients with concomitant neurological disorder and psychiatric disorders.

          -  Patients with sleep-related breathing disorders whose apnea/hypopnea index (AHI) was 5
             pauses per hour above.

          -  Patients with Restless Leg Syndrome &amp; Periodic Limbs Movements whose index was more
             than 5 per hour.

          -  Patients who are pregnant or breast-feeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yue-Joe Lee, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry, National Taiwan University</affiliation>
  </overall_official>
  <verification_date>October 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>September 14, 2005</last_update_submitted>
  <last_update_submitted_qc>September 14, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Narcolepsy</mesh_term>
    <mesh_term>Cataplexy</mesh_term>
    <mesh_term>Disorders of Excessive Somnolence</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Modafinil</mesh_term>
    <mesh_term>Armodafinil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

